Intuitive Surgical Inc. (ISRG) SVP Sells $2,908,657.50 in Stock

Intuitive Surgical Inc. (NASDAQ:ISRG) SVP Curet Myriam sold 4,250 shares of Intuitive Surgical stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $684.39, for a total value of $2,908,657.50. Following the transaction, the senior vice president now directly owns 3,133 shares of the company’s stock, valued at $2,144,193.87. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

An institutional investor recently bought a new position in Intuitive Surgical stock. Eagle Asset Management bought a new stake in Intuitive Surgical Inc. (NASDAQ:ISRG) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 51,856 shares of the company’s stock, valued at approximately $23,830,000. Eagle Asset Management owned approximately 0.14% of Intuitive Surgical as of its most recent SEC filing.

Shares of Intuitive Surgical Inc. (NASDAQ:ISRG) traded up 1.03% during trading on Thursday, reaching $690.09. The company’s stock had a trading volume of 257,066 shares. The firm has a market cap of $26.56 billion and a PE ratio of 39.16. The company’s 50 day moving average price is $662.74 and its 200 day moving average price is $608.96. Intuitive Surgical Inc. has a 12 month low of $447.00 and a 12 month high of $720.01.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, July 19th. The company reported $5.62 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.65. The company earned $670 million during the quarter, compared to analyst estimates of $640.69 million. During the same period in the previous year, the company posted $4.57 EPS. On average, equities analysts predict that Intuitive Surgical Inc. will post $21.30 earnings per share for the current year.

A number of brokerages have issued reports on ISRG. Northland Securities cut Intuitive Surgical from a “market perform” rating to an “under perform” rating and set a $600.00 price objective for the company. in a report on Thursday, July 21st. Zacks Investment Research raised Intuitive Surgical from a “sell” rating to a “hold” rating and set a $772.00 price objective for the company in a report on Friday, July 22nd. Citigroup Inc. lifted their price objective on Intuitive Surgical from $723.00 to $779.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. Barclays PLC lifted their price objective on Intuitive Surgical from $690.00 to $750.00 and gave the company an “overweight” rating in a report on Wednesday, July 20th. Finally, Canaccord Genuity lifted their price objective on Intuitive Surgical from $700.00 to $750.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have given a buy rating to the stock. Intuitive Surgical presently has a consensus rating of “Buy” and a consensus price target of $698.58.

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.